"The Report
MediPoint: Biopsy Devices - Global Analysis and Market Forecasts
provides information on pricing, market analysis, shares, forecast,
and company profiles for key industry participants. -
MarketResearchReports.biz"
Cancer is the uncontrolled
growth of abnormal cells in the body. It can affect numerous organs
and tissues of the body. When a patient is suspected of having a
particular type of cancer, a biopsy procedure is performed to extract
a target tissue sample for histological analysis. This intervention
typically provides a definitive cancer diagnosis for the patient.
Given that these procedures play such an important role in the
diagnostic pathway for various cancers, medical device manufacturers
have worked to develop biopsy devices that maximize the volume and
quality of the tissue samples, as well as decrease their negative
impact on the patients body. As seen with other medical device
markets, less invasive biopsy techniques have entered the market and
have established a new gold standard in many global regions.
View Report At :
http://www.marketresearchreports.biz/analysis/189450
For this market analysis, the
biopsy devices market is segmented by cancer indication and by the
type of biopsy procedure performed. Beyond providing a general
analysis and forecast for each device segment in different global
regions from 20102019, this report offers a more granular approach by
assessing the adoption patterns of the different biopsy procedure
types for specific cancer indications in specific geographies. This
report and forecast focus on the adoption patterns of surgical
biopsies, fine needle aspiration (FNA) devices, core needle biopsy
(CNB) devices, and vacuum-assisted biopsy (VAB) devices in the
diagnosis of breast, prostate, lung, liver, and thyroid cancers.
Additionally, this report and forecast focus on these adoption
patterns in the 10 major global markets, which include the United
States, France, Germany, Italy, Spain, the United Kingdom, Japan,
Brazil, China, and India. This segmentation provides better business
intelligence, so that more effective actions can be taken.
While the biopsy devices market
has matured quite significantly, there are still significant barriers
to overcome and opportunities for growth. While the US has seen the
rapid adoption of VAB devices in the diagnosis of breast cancer, this
market segment will be subjected to immense pricing pressure during
the forecast period covered in this report. Changes in the
reimbursement rates for image-guided breast biopsy procedures will
affect both the average selling prices (ASPs) of these devices and
the adoption levels of alternative tissue-extraction devices and
procedures, including CNBs and open surgical biopsies. Additionally,
the emerging economies will provide opportunities for growth as
access to healthcare improves, adoption of FNA decreases, and
governments work towards implementing cancer screening programs. This
report is intended to elaborate on these market opportunities and
barriers to help current and future competitors navigate the market.
Download Sample copy of this
Report at:
Highlights
Key Questions Answered
At the start of 2014, the
reimbursement scheme for imaged-guided breast biopsy procedures
performed in the US underwent significant changes in coding structure
and cost levels. (Q). How will this affect the adoption of VAB and
CNB devices in the country? (Q). To what extent will the ASPs of VAB
devices be affected?
The biopsy devices markets
in the developing economies of the Asia-Pacific (APAC) region and
Brazil have higher Compound Annual Growth Rates (CAGRs) than any
other country included in this report. (Q). Which countries will have
the highest CAGRs in the FNA market, the CNB market, and the VAB
market?
The major players in the
VAB and CNB markets are drastically different. (Q). What is the
global company share in the VAB and CNB markets? (Q). How will their
market share shift through 2019?
New technologies, such as
liquid and optical biopsies, are being developed as less invasive
techniques to obtain a cancer diagnosis. (Q). What is the likelihood
that these technologies could replace the conventional biopsy
devices? (Q). Which companies are the furthest along in the
development of these technologies?
The benefits of mass
screening programs on prostate cancer mortality are controversial.
(Q). What are the results of the major randomized clinical trials
assessing a prostate cancer screening programs effectiveness? (Q).
How will this impact the institution of a mass prostate cancer
screening program in the countries covered in this report?
Reasons to buy
What Do Physicians Think?
quotes provide a unique insight into how healthcare professionals are
reacting to events within the industry, and what their responses
could mean for industry strategists. This information is essential
for all strategic decision-makers in every organization, allowing
them to act on high-quality information.
Table of Contents
1 Table of Contents
1 Table of Contents 6
1.1 List of Tables 10
1.2 List of Figures 13
2 Introduction 15
2.1 Overview 15
2.2 Catalyst 16
2.3 Related Reports 16
3 Industry Overview 17
3.1 Types of Biopsies 17
3.1.1 Surgical Biopsy 17
3.1.2 Fine Needle Aspiration 17
3.1.3 Core Needle Biopsy 18
3.1.4 Vacuum-Assisted Biopsy 19
3.2 Biopsy Procedure Trends 19
3.2.1 Global 19
3.2.2 United States 20
3.2.3 EU 22
3.2.4 South America 29
3.2.5 Asia-Pacific Region 30
3.3 Market Access to Cancer
Screening Programs 36
3.3.1 Regulation 36
3.3.2 Biopsy Device Adoption
Patterns 39
3.3.3 Reimbursement Trends 43
3.4 Regulatory Issues/Recalls
44
3.5 Mergers &
Acquisitions/Key Partnerships 45
3.5.1 Hologic Acquires Suros
Surgical Systems 45
3.5.2 C. R. Bard Acquires
SenoRx 45
3.5.3 Devicor Medical Products
Acquires Breast Care Portfolio from Ethicon Endo-Surgery 46
3.6 Economic Impact of Cancer
Screening and Treatment 46
3.7 Additional Indications for
Biopsy Devices 47
4 Unmet Needs 48
4.1 Overview 48
4.2 More Efficient Screening
Tests for Prostate Cancer 48
4.3 More Efficient Screening
Tests for Breast Cancer 49
4.4 More Efficient Screening
Guidelines for Thyroid Cancer 49
4.5 Screening Tests That Can
Provide Histological Analysis In Situ 50
5 Market Opportunity Analysis
51
5.1 Increase Marketing for
Vacuum-Assisted Biopsy Devices in European Countries 51
5.2 Bundling Solutions 52
5.3 Focus Efforts on Chinas
Increasing Adoption of VAB Devices 53
5.4 Market for Prostate Cancer
Screening Coverage in Europe 53
About us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
Mr.
Nachiket
State
Tower
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-621-2074
No comments:
Post a Comment